Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last C$0.45 CAD
Change Today -0.015 / -3.23%
Volume 12.0K
MWX On Other Exchanges
Symbol
Exchange
Venture
As of 1:57 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

medworxx solutions inc (MWX) Snapshot

Open
C$0.46
Previous Close
C$0.47
Day High
C$0.46
Day Low
C$0.45
52 Week High
03/12/15 - C$0.55
52 Week Low
12/10/14 - C$0.30
Market Cap
12.3M
Average Volume 10 Days
16.1K
EPS TTM
C$-0.06
Shares Outstanding
27.3M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MEDWORXX SOLUTIONS INC (MWX)

Related News

No related news articles were found.

medworxx solutions inc (MWX) Related Businessweek News

No Related Businessweek News Found

medworxx solutions inc (MWX) Details

Medworxx Solutions Inc. provides health information technology solutions to hospitals in Canada, the United States, and the United Kingdom. It develops and sells technologies that are used to assist health care practitioners’ abilities to communicate, aggregate, and analyze knowledge. The company provides Medworxx patient flow software to streamline patient flow and safeguard the appropriateness of care and transitions; and Medworxx compliance and education solutions enable healthcare organizations to create and deploy relevant content. It also offers maintenance and hosting services, and consulting services. The company was founded in 2004 and is headquartered in Toronto, Canada.

Founded in 2004

medworxx solutions inc (MWX) Top Compensated Officers

Chief Executive Officer, President and Execut...
Total Annual Compensation: C$250.5K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: C$174.9K
Senior Vice President of Sales
Total Annual Compensation: C$120.2K
Vice President of Product Development & Servi...
Total Annual Compensation: C$159.1K
Vice President of Patient Flow Process Improv...
Total Annual Compensation: C$147.2K
Compensation as of Fiscal Year 2013.

medworxx solutions inc (MWX) Key Developments

Medworxx Solutions Inc Announces Consolidated Earnings Results for the Fourth Quarter and Year Ended December 31, 2014

Medworxx Solutions Inc. announced consolidated earnings results for the fourth quarter and year ended December 31, 2014. For the quarter ended December 31, 2014, the Company was profitable with net income of $55,634 as compared to a net loss of $330,721 for the three months ended December 31, 2013. Revenue was $1.8 million, representing an increase of 14.0% over revenues of $1.5 million for the same period last year. For the year ended December 31, 2014, revenue was $6.2 million, representing an increase of 4.1% over revenues of $5.9 million for the year ended December 31, 2013.

Capio France Selects Medworxx as Patient Flow Software Provider

Medworxx Solutions Inc. announce that Capio France has selected Medworxx as their Patient Flow software provider. The Medworxx Clinical Criteria module will enable the hospital to identify the clinical appropriateness of each patient's level of care, each day, and will provide clinicians with the ability to match patients with the right level of care, at the right time and in the most appropriate setting. The solution combines a unique methodology, process, communication, technology, and clinical information as a decision support tool for all levels of an organization. The Medworxx Patient Flow Platform provides hospitals with tools to bridge clinical and operational perspectives on daily patient flow 'addressing issues of overcapacity, wait times and care coordination.

Medworxx Solutions Hires Advisor For Strategic Review

After the completion of a formal selection process by a special committee formed to examine and consider strategic and financial alternatives available to Medworxx Solutions Inc (TSXV:MWX), Medworxx retained Berkery, Noyes & Co., LLC as its advisor, as it explores strategic alternatives to maximize shareholder value. It is Medworxx's current intention not to disclose developments with respect to the strategic review process until the Board of Directors has approved a specific transaction or otherwise determines that disclosure is necessary or appropriate.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MWX:CN C$0.45 CAD -0.015

MWX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MWX.
View Industry Companies
 

Industry Analysis

MWX

Industry Average

Valuation MWX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.8x
Price/Book -- Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDWORXX SOLUTIONS INC, please visit www.medworxx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.